Iloperidone

This classification denotes an antipsychotic agent with the molecular formula C24H27FN2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VPO7KJ050N, chemically known as 4-(3-(4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3-methoxyacetophenone but generally known as iloperidone, which bears US NIH Compound Identifier 71360. European Medicines Agency schedules Iloperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08135MIG. The term ILOPERIDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 No. 3 1994, List 34). ILOPERIDONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule iloperidone under HS 29349990 and SITC 51579. As of Q4 2014, ILOPERIDONE remains the US FDA Preferred Term for this commodity. Iloperidone bears US NLM identifiers UMLS ID C0247194 and NCI Concept Code C83784. SMILES: FC1CC2ONC(C3CCN(CC3)CCCOC3C(OC)CC(CC3)C(=O)C)C2CC1.